$SNWV
SANUWAVE Health, Inc.

2023 Q3 Form 10-Q Financial Statement

#000114036123039074 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $4.953M $4.675M
YoY Change 18.89% 20.43%
Cost Of Revenue $1.412M $1.202M
YoY Change 133.0% 9.67%
Gross Profit $3.541M $3.473M
YoY Change -0.53% 24.66%
Gross Profit Margin 71.49% 74.29%
Selling, General & Admin $3.720M $2.216M
YoY Change -26.39% -51.92%
% of Gross Profit 105.06% 63.81%
Research & Development $165.0K $139.0K
YoY Change 5.1% -18.71%
% of Gross Profit 4.66% 4.0%
Depreciation & Amortization $265.0K $256.0K
YoY Change -54.86% 0.39%
% of Gross Profit 7.48% 7.37%
Operating Expenses $4.072M $2.542M
YoY Change -24.59% -47.63%
Operating Profit -$531.0K $931.0K
YoY Change -71.14% -145.02%
Interest Expense -$23.17M -$8.193M
YoY Change -1631.33% -264.49%
% of Operating Profit -880.02%
Other Income/Expense, Net -$23.17M -$8.193M
YoY Change -1723.62% -271.76%
Pretax Income -$23.70M -$7.262M
YoY Change 5638.5% -368.76%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$23.70M -$7.262M
YoY Change 5638.5% -368.76%
Net Earnings / Revenue -478.5% -155.34%
Basic Earnings Per Share -$0.03 -$0.01
Diluted Earnings Per Share -$0.03 -$0.01
COMMON SHARES
Basic Shares Outstanding 1.026B 548.7M
Diluted Shares Outstanding 893.0M 582.3M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.095M $332.0K
YoY Change -1.53% -77.63%
Cash & Equivalents $1.095M $332.0K
Short-Term Investments
Other Short-Term Assets $1.355M $2.051M
YoY Change -29.97% 73.67%
Inventory $1.713M $900.0K
Prepaid Expenses
Receivables $3.231M $2.818M
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.394M $6.101M
YoY Change 7.74% 14.27%
LONG-TERM ASSETS
Property, Plant & Equipment $1.079M $1.050M
YoY Change 60.33% 96.26%
Goodwill $7.260M $7.260M
YoY Change 0.0% 0.0%
Intangibles $4.609M $4.786M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $12.95M $13.10M
YoY Change -2.25% -1.42%
TOTAL ASSETS
Total Short-Term Assets $7.394M $6.101M
Total Long-Term Assets $12.95M $13.10M
Total Assets $20.34M $19.20M
YoY Change 1.16% 3.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.623M $4.859M
YoY Change -8.55% -31.4%
Accrued Expenses $6.359M $6.351M
YoY Change 55.1% 7.64%
Deferred Revenue $68.00K $67.00K
YoY Change -72.69% 4.69%
Short-Term Debt $27.32M $16.12M
YoY Change -14.64% 986.46%
Long-Term Debt Due $10.05M $26.06M
YoY Change -30.93% 15.27%
Total Short-Term Liabilities $85.43M $79.28M
YoY Change 62.84% 54.54%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $834.0K $730.0K
YoY Change 78.21% 117.91%
Total Long-Term Liabilities $862.0K $758.0K
YoY Change 73.79% -32.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $85.43M $79.28M
Total Long-Term Liabilities $862.0K $758.0K
Total Liabilities $86.30M $80.04M
YoY Change 62.94% 52.67%
SHAREHOLDERS EQUITY
Retained Earnings -$238.3M -$214.6M
YoY Change 28.05% 15.57%
Common Stock $1.026M $562.0K
YoY Change 86.89% 6.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$65.95M -$60.84M
YoY Change
Total Liabilities & Shareholders Equity $20.34M $19.20M
YoY Change 1.16% 3.08%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$23.70M -$7.262M
YoY Change 5638.5% -368.76%
Depreciation, Depletion And Amortization $265.0K $256.0K
YoY Change -54.86% 0.39%
Cash From Operating Activities -$2.038M -$844.0K
YoY Change -74.45% -59.21%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $151.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $13.00K $0.00
YoY Change -82.43% -100.0%
Cash From Investing Activities $13.00K -$151.0K
YoY Change -82.43% -125.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.930M 2.080M
YoY Change -74.47% -21.03%
NET CHANGE
Cash From Operating Activities -2.038M -844.0K
Cash From Investing Activities 13.00K -151.0K
Cash From Financing Activities 1.930M 2.080M
Net Change In Cash -95.00K 1.085M
YoY Change -72.14% -5.9%
FREE CASH FLOW
Cash From Operating Activities -$2.038M -$844.0K
Capital Expenditures $0.00 $151.0K
Free Cash Flow -$2.038M -$995.0K
YoY Change -74.45% -51.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
10618000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-11343000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1337000
us-gaap Interest Paid Net
InterestPaidNet
2045000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-38958000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-35535000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-35535000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-41010000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-53791000
snwv Loss On Issuance Of Debt
LossOnIssuanceOfDebt
3434000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1304000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-898000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-733000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-115000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
336000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
27000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
718000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-486000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
948000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
169000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-169000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
948000
us-gaap Net Income Loss
NetIncomeLoss
-20342000
us-gaap Net Income Loss
NetIncomeLoss
-3457000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
515000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
446000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
313000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
52000
snwv Loss On Issuance Of Debt
LossOnIssuanceOfDebt
0
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3955000
us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
3606000
us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
1327000
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-16000
snwv Payments To Factoring Agent Net
PaymentsToFactoringAgentNet
1167000
snwv Payments To Factoring Agent Net
PaymentsToFactoringAgentNet
-55000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
100000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
29000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
865000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1153000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
619000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1182000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1484000
us-gaap Interest Paid Net
InterestPaidNet
908000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001417663
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
850000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
0
CY2023Q2 us-gaap Bridge Loan
BridgeLoan
1476000
CY2022Q4 us-gaap Bridge Loan
BridgeLoan
0
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
582328811
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
538560051
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
579178811
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
532589825
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
582328811
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
871984091
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
579178811
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
532589825
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
224000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-7262000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-9000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-60838000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-38067000
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
888000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
1644000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
0
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
527000
us-gaap Profit Loss
ProfitLoss
-20342000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-13000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-60838000
snwv Stock Issued During Period Value Cashless Warrant Exercises
StockIssuedDuringPeriodValueCashlessWarrantExercises
2166000
snwv Stock Issued During Period Warrants Exercised Value
StockIssuedDuringPeriodWarrantsExercisedValue
100000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3720000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
888000
us-gaap Profit Loss
ProfitLoss
-3457000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
6000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
224000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
888000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-211000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1710000
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-108000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1215000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5201000
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
2940000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1202000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
1476000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
2130000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
85000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
121000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1426000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5104000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-13000
snwv Warrants Issued In Conjunction With Senior Secured And Convertible Promissory Note Payable
WarrantsIssuedInConjunctionWithSeniorSecuredAndConvertiblePromissoryNotePayable
570000
snwv Warrants Issued In Conjunction With Senior Secured And Convertible Promissory Note Payable
WarrantsIssuedInConjunctionWithSeniorSecuredAndConvertiblePromissoryNotePayable
2654000
snwv Common Shares Issued For Advisory Shares
CommonSharesIssuedForAdvisoryShares
302000
snwv Common Shares Issued For Advisory Shares
CommonSharesIssuedForAdvisoryShares
0
snwv Embedded Conversion Option With Issuances Of Convertible Debt
EmbeddedConversionOptionWithIssuancesOfConvertibleDebt
157000
snwv Embedded Conversion Option With Issuances Of Convertible Debt
EmbeddedConversionOptionWithIssuancesOfConvertibleDebt
0
snwv Reclassification Of Warrant Liability Due To Cashless Warrant Exercise
ReclassificationOfWarrantLiabilityDueToCashlessWarrantExercise
0
snwv Reclassification Of Warrant Liability Due To Cashless Warrant Exercise
ReclassificationOfWarrantLiabilityDueToCashlessWarrantExercise
2167000
snwv Common Shares Issued In Conjunction With Senior Secured Promissory Note Payable
CommonSharesIssuedInConjunctionWithSeniorSecuredPromissoryNotePayable
0
snwv Common Shares Issued In Conjunction With Senior Secured Promissory Note Payable
CommonSharesIssuedInConjunctionWithSeniorSecuredPromissoryNotePayable
3720000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
332000
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
850000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1182000
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
26776000
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1411000
CY2023Q2 snwv Debt Instrument Remaining Embedded Conversion Option
DebtInstrumentRemainingEmbeddedConversionOption
693000
CY2023Q2 snwv Convertible Promissory Notes And Convertible Promissory Note Related Parties Current
ConvertiblePromissoryNotesAndConvertiblePromissoryNoteRelatedPartiesCurrent
26058000
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
25548000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
3766000
CY2022Q4 snwv Debt Instrument Remaining Embedded Conversion Option
DebtInstrumentRemainingEmbeddedConversionOption
2340000
CY2022Q4 snwv Convertible Promissory Notes And Convertible Promissory Note Related Parties Current
ConvertiblePromissoryNotesAndConvertiblePromissoryNoteRelatedPartiesCurrent
24122000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2500000000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4413000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3538000
CY2023Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
262000
CY2022Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
344000
CY2023Q2 us-gaap Revenues
Revenues
4675000
CY2022Q2 us-gaap Revenues
Revenues
3882000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7905000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6389000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
545000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
688000
us-gaap Revenues
Revenues
8450000
us-gaap Revenues
Revenues
7077000

Files In Submission

Name View Source Status
0001140361-23-039074-index-headers.html Edgar Link pending
0001140361-23-039074-index.html Edgar Link pending
0001140361-23-039074.txt Edgar Link pending
0001140361-23-039074-xbrl.zip Edgar Link pending
brhc20057217_10q.htm Edgar Link pending
brhc20057217_ex31-1.htm Edgar Link pending
brhc20057217_ex31-2.htm Edgar Link pending
brhc20057217_ex32-1.htm Edgar Link pending
brhc20057217_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
brhc20057217_10q_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snwv-20230630.xsd Edgar Link pending
snwv-20230630_lab.xml Edgar Link unprocessable
snwv-20230630_pre.xml Edgar Link unprocessable
snwv-20230630_cal.xml Edgar Link unprocessable
snwv-20230630_def.xml Edgar Link unprocessable